Intervention not reported
Identification of IPV by type of healthcare setting ‐ Antenatal clinics · women attending healthcare settings for any health‐related reason
1 finding from 1 review
Intervention not reported
Identification of IPV by type of healthcare setting ‐ Maternal health services · women attending healthcare settings for any health‐related reason
1 finding from 1 review
Intervention not reported
Identification of IPV by type of healthcare setting ‐ Emergency departments · women attending healthcare settings for any health‐related reason
1 finding from 1 review
Intervention not reported
Identification of IPV by type of healthcare setting ‐ Hospital‐based primary care · women attending healthcare settings for any health‐related reason
1 finding from 1 review
Intervention not reported
Referrals (assessed immediately) · women attending healthcare settings for any health‐related reason
1 finding from 1 review
Intervention not reported
Identification of IPV (non‐clinically based, assessed immediately) · women attending healthcare settings for any health‐related reason
1 finding from 1 review
Intervention not reported
Outcomes1 · adult male patients
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
All‐cause mortality · adult male patients
The intervention showed no clear difference in all‐cause mortality (moderate certainty).
1 finding from 1 review
Intervention not reported
Prostate cancer‐specific mortality · adult male patients
The intervention showed no clear difference in prostate cancer‐specific mortality (moderate certainty).
1 finding from 1 review
Intervention not reported
Prostate cancer diagnosis · adult male patients
The intervention may leads to higher prostate cancer diagnosis (low certainty).
1 finding from 1 review
Intervention not reported
Tumour stage (localised T1‐T2, N0, M0) · adult male patients
The intervention may leads to higher tumour stage (localised T1‐T2, N0, M0) (low certainty).
1 finding from 1 review
Intervention not reported
Tumour stage (advanced T3‐4, N1, M1) · adult male patients
The intervention probably leads to lower tumour stage (advanced T3‐4, N1, M1) (moderate certainty).
1 finding from 1 review
Intervention not reported
CRC Mortality ‐ Flexible sigmoidoscopy · Asymptomatic individuals
The intervention leads to lower CRC Mortality ‐ Flexible sigmoidoscopy (high certainty).
1 finding from 1 review
Intervention not reported
CRC Mortality ‐ Faecal occult blood testing · Asymptomatic individuals
The intervention leads to lower CRC Mortality ‐ Faecal occult blood testing (high certainty).
1 finding from 1 review
Intervention not reported
CRC incidence ‐ Flexible sigmoidoscopy · Asymptomatic individuals
The intervention probably leads to lower CRC incidence ‐ Flexible sigmoidoscopy (moderate certainty).
1 finding from 1 review
Intervention not reported
CRC incidence ‐ Faecal occult blood testing · Asymptomatic individuals
The intervention leads to lower CRC incidence ‐ Faecal occult blood testing (high certainty).
1 finding from 1 review
Intervention not reported
All‐cause Mortality ‐ Flexible sigmoidoscopy · Asymptomatic individuals
The intervention showed no clear difference in all‐cause Mortality ‐ Flexible sigmoidoscopy (high certainty).
1 finding from 1 review
Intervention not reported
All‐cause Mortality ‐ Faecal occult blood testing · Asymptomatic individuals
The intervention leads to higher all‐cause Mortality ‐ Faecal occult blood testing (high certainty).
1 finding from 1 review
Intervention not reported
Oesophageal cancer‐specific mortality ‐ not measured · patients with oesophageal cancer
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Secondary outcomes ‐ not measured · patients with oesophageal cancer
The review found no eligible studies for this question.
1 finding from 1 review